Psilocybin Spurs Brain Activity in Patients With Depression, Small Study Shows
The chemical derived from psychedelic mushrooms helped alleviate symptoms of depression and generated detectable neural responses that lasted weeks.
On Day 100, Mayor Adams Has Covid-19
Eric Adams tested positive after a series of public events promoting his first 100 days as mayor. He reminded eligible New Yorkers to take antivirals.
Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.
In India, Parents of Children with Rare Disease Plea for Help Online
India makes many of the world’s drugs, but treatments for rare diseases like spinal muscular atrophy are imported and prohibitively costly. In desperation, parents are raising funds on social media.
Inside a Campaign to Get Medicare Coverage for a New Alzheimer’s Drug
The Alzheimer’s Association has pushed relentlessly to get broad access to Aduhelm, despite safety risks and uncertain evidence that it helps patients.
The F.D.A. Suspends Use of Glaxo Antibody Drug in the U.S.
Manufacturers said lab testing revealed that the authorized dosage of the drug was not sufficiently potent against BA.2.
House Passes Bill to Limit Cost of Insulin to $35 a Month
The bill stands to benefit millions of Americans with diabetes, but to become law, it will need to attract at least 10 Republican votes in the Senate
Una nueva ola de covid se avecina. Así puedes prepararte
Tomar estas siete medidas ahora puede reducir tu riesgo y minimizar la perturbación en la vida de tu familia.
New ALS Treatment, AMX0035, Lacks Evidence of Benefit, FDA Panel Finds
With a 6-4 vote, the group of independent advisers to the agency narrowly concluded that results from another clinical trial are needed to assess whether the therapy, called AMX0035, can help patients.
Ivermectin Does Not Reduce Risk of Covid Hospitalization, Large Study Finds
“At some point it will become a waste of resources to continue studying an unpromising approach,” one expert said.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.